Document is current
Any future updates will be listed below
-
Authors
Roux, Jérémie
Hafner, Marc
Bandara, Samuel
Sims, Joshua J
Hudson, Hannah
Chai, Diana
Sorger, Peter K
-
Funding
Funding for this research was provided by:
NIH (CA139980)
NIH (HL127365)
Swiss National Science Foundation (PBELP3_140652)
Swiss National Science Foundation (P300P3_147876)
Marie Curie International Incoming Fellowship
7th European Community Framework Programme (N° 626190)
7th European Community Framework Programme (FP7‐ PEOPLE‐2013‐IIF)
- License Information
-
More Information
Article History
Received: 15 July 2014
Revised: 17 March 2015
Accepted: 27 March 2015
First Online: 7 May 2015
Conflict of interest
: PKS is a founder of Merrimack Pharmaceuticals and chair of its scientific advisory board; this relationship is actively managed by Harvard Medical School (HMS) in accordance with NIH regulations. The remaining authors declare that they have no conflict of interest.
